X4 Pharmaceuticals Ownership 2024 | Who Owns X4 Pharmaceuticals Now?
Institutional Ownership
2.56%
Insider Ownership
1.15%
Retail Ownership
96.30%
Institutional Holders
27.00
X4 Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 8.46% | 1.08% | 16,915,784 | - | - | 9,811,155 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 7.49% | 0.65% | 14,986,793 | - | - | 8,692,340 | Jun 30, 2024 |
| BLACKROCK INC. | 5.34% | 0.00% | 10,675,963 | 1,940,096 | 22.21% | 6,192,059 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.15% | 0.00% | 8,290,050 | 462,323 | 5.91% | 4,808,230 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 3.57% | 0.08% | 7,133,515 | - | - | 4,137,439 | Jun 30, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2.31% | 0.29% | 4,623,683 | 1,150,000 | 33.11% | 2,681,736 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.14% | 0.00% | 4,276,315 | - | - | 2,480,263 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 2.03% | 0.21% | 4,051,000 | -528,926 | -11.55% | 2,349,580 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.77% | 0.05% | 3,545,454 | - | - | 2,056,363 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.76% | 0.00% | 3,515,538 | 570,114 | 19.36% | 2,039,220 | Jun 30, 2024 |
| AXA S.A. | 1.54% | 0.01% | 3,076,077 | 1,705 | 0.06% | 1,784,125 | Jun 30, 2024 |
| STATE STREET CORP | 1.38% | 0.00% | 2,763,790 | 240,235 | 9.52% | 1,602,998,000 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 1.27% | 0.00% | 2,546,458 | 111,032 | 4.56% | 1,476,946 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.25% | 0.39% | 2,499,800 | -1,088,627 | -30.34% | 1,449,884 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.63% | 0.00% | 1,269,693 | 354,693 | 38.76% | 736,421 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.58% | 0.04% | 1,160,521 | -175,000 | -13.10% | 673,102 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.53% | 0.00% | 1,056,006 | 1,518 | 0.14% | 612,484,000 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.40% | 0.06% | 806,616 | 1,257 | 0.16% | 467,837 | Jun 30, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 0.33% | 0.22% | 659,020 | 659,020 | 100.00% | 382,232 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.27% | 0.00% | 543,084 | -106,916 | -16.45% | 314,989 | Jun 30, 2024 |
X4 Pharmaceuticals's largest institutional shareholder is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, holding 8.46% of the company's total share outstanding, currently valued at $9.81M. The top 10 institutional shareholders own together 39.01% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 8.46% | 1.08% | 16,915,784 | - | - | 9,811,155 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 7.49% | 0.65% | 14,986,793 | - | - | 8,692,340 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.25% | 0.39% | 2,499,800 | -1,088,627 | -30.34% | 1,449,884 | Jun 30, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2.31% | 0.29% | 4,623,683 | 1,150,000 | 33.11% | 2,681,736 | Jun 30, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 0.17% | 0.24% | 335,000 | - | - | 194,300 | Jun 30, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 0.33% | 0.22% | 659,020 | 659,020 | 100.00% | 382,232 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 2.03% | 0.21% | 4,051,000 | -528,926 | -11.55% | 2,349,580 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.22% | 0.14% | 448,594 | 448,594 | 100.00% | 260,184 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 3.57% | 0.08% | 7,133,515 | - | - | 4,137,439 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.40% | 0.06% | 806,616 | 1,257 | 0.16% | 467,837 | Jun 30, 2024 |
| K2 PRINCIPAL FUND, L.P. | 0.24% | 0.05% | 489,158 | 489,158 | 100.00% | 283,712 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.77% | 0.05% | 3,545,454 | - | - | 2,056,363 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.58% | 0.04% | 1,160,521 | -175,000 | -13.10% | 673,102 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.09% | 0.04% | 180,993 | - | - | 105,000 | Jun 30, 2024 |
| HOLISTIC PLANNING, LLC | 0.01% | 0.01% | 13,800 | - | - | 19,182 | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | 0.09% | 0.01% | 177,032 | 138,966 | 365.07% | 102,679 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.08% | 0.01% | 163,367 | 163,367 | 100.00% | 94,753 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.01% | 111,245 | 111,245 | 100.00% | 64,522 | Jun 30, 2024 |
| AXA S.A. | 1.54% | 0.01% | 3,076,077 | 1,705 | 0.06% | 1,784,125 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.63% | 0.00% | 1,269,693 | 354,693 | 38.76% | 736,421 | Jun 30, 2024 |
The largest X4 Pharmaceuticals shareholder by % of total assets is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC. The company owns 16.92M shares of X4 Pharmaceuticals (XFOR), representing 1.08% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.34% | 0.00% | 10,675,963 | 1,940,096 | 22.21% | 6,192,059 | Jun 30, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2.31% | 0.29% | 4,623,683 | 1,150,000 | 33.11% | 2,681,736 | Jun 30, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 0.33% | 0.22% | 659,020 | 659,020 | 100.00% | 382,232 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.76% | 0.00% | 3,515,538 | 570,114 | 19.36% | 2,039,220 | Jun 30, 2024 |
| K2 PRINCIPAL FUND, L.P. | 0.24% | 0.05% | 489,158 | 489,158 | 100.00% | 283,712 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.15% | 0.00% | 8,290,050 | 462,323 | 5.91% | 4,808,230 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.22% | 0.14% | 448,594 | 448,594 | 100.00% | 260,184 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.21% | 0.00% | 424,042 | 388,115 | 1080.29% | 245,944 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.63% | 0.00% | 1,269,693 | 354,693 | 38.76% | 736,421 | Jun 30, 2024 |
| STATE STREET CORP | 1.38% | 0.00% | 2,763,790 | 240,235 | 9.52% | 1,602,998,000 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.11% | 0.00% | 227,246 | 227,246 | 100.00% | 131,803 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.10% | 0.00% | 200,000 | 200,000 | 100.00% | 5,000 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.08% | 0.01% | 163,367 | 163,367 | 100.00% | 94,753 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.08% | 0.00% | 164,248 | 143,002 | 673.08% | 95,264,000 | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | 0.09% | 0.01% | 177,032 | 138,966 | 365.07% | 102,679 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.23% | 0.00% | 469,372 | 133,398 | 39.70% | 272,236 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.22% | - | 438,208 | 114,365 | 35.31% | 254,161 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.01% | 111,245 | 111,245 | 100.00% | 64,522 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 1.27% | 0.00% | 2,546,458 | 111,032 | 4.56% | 1,476,946 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 90,404 | 90,404 | 100.00% | 52,434 | Jun 30, 2024 |
As of Jun 30 2024, X4 Pharmaceuticals's largest institutional buyer is BLACKROCK INC.. The company purchased 1.94M stocks of XFOR, valued at $6.19M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -2,413,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.11% | - | 229,336 | -1,177,089 | -83.69% | 133,015 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.25% | 0.39% | 2,499,800 | -1,088,627 | -30.34% | 1,449,884 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.09% | - | 171,190 | -887,740 | -83.83% | 99,291 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | - | - | - | -535,000 | -100.00% | - | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 2.03% | 0.21% | 4,051,000 | -528,926 | -11.55% | 2,349,580 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | - | - | - | -400,000 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.05% | - | 93,821 | -354,887 | -79.09% | 54,000 | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | - | - | - | -342,363 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -321,021 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.58% | 0.04% | 1,160,521 | -175,000 | -13.10% | 673,102 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.27% | 0.00% | 543,084 | -106,916 | -16.45% | 314,989 | Jun 30, 2024 |
| AMUNDI | - | - | - | -81,305 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -70,422 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.03% | - | 62,030 | -67,054 | -51.95% | 35,978 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -61,735 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -55,296 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -47,573 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.01% | - | 17,085 | -44,490 | -72.25% | 9,909 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -29,507 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, X4 Pharmaceuticals's biggest institutional seller is AVIDITY PARTNERS MANAGEMENT LP. The company sold -2.41M shares of XFOR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 0.33% | 0.22% | 659,020 | 659,020 | 100.00% | 382,232 | Jun 30, 2024 |
| K2 PRINCIPAL FUND, L.P. | 0.24% | 0.05% | 489,158 | 489,158 | 100.00% | 283,712 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.22% | 0.14% | 448,594 | 448,594 | 100.00% | 260,184 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.11% | 0.00% | 227,246 | 227,246 | 100.00% | 131,803 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.10% | 0.00% | 200,000 | 200,000 | 100.00% | 5,000 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.08% | 0.01% | 163,367 | 163,367 | 100.00% | 94,753 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 90,404 | 90,404 | 100.00% | 52,434 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.04% | - | 75,405 | 75,405 | 100.00% | 43,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 63,453 | 63,453 | 100.00% | 36,803 | Jun 30, 2024 |
| ALLRED CAPITAL MANAGEMENT, LLC | 0.01% | 0.00% | 12,800 | 12,800 | 100.00% | 7,424 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.01% | 0.00% | 10,362 | 10,362 | 100.00% | 6,010 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,901 | 1,901 | 100.00% | 1,102 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 911 | 911 | 100.00% | 1,000 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | - | 503 | 503 | 100.00% | 292 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 400 | 400 | 100.00% | 232 | Jun 30, 2024 |
| HIGHMARK WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 180 | 180 | 100.00% | 104 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | 49 | 49 | 100.00% | 28 | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | 16 | 16 | 100.00% | 9 | Jun 30, 2024 |
X4 Pharmaceuticals's largest new institutional shareholder by number of shares is VELAN CAPITAL INVESTMENT MANAGEMENT LP, purchased 659.02K shares, valued at $382.23K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -2,413,000 | -100.00% | - | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | - | - | - | -535,000 | -100.00% | - | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | - | - | - | -400,000 | -100.00% | - | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | - | - | - | -342,363 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -321,021 | -100.00% | - | Jun 30, 2024 |
| AMUNDI | - | - | - | -81,305 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -70,422 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -61,735 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -55,296 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -47,573 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -29,507 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -20,822 | -100.00% | - | Jun 30, 2024 |
| GRIMES & COMPANY, INC. | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| TOTAL CLARITY WEALTH MANAGEMENT, INC. | - | - | - | -13,681 | -100.00% | - | Jun 30, 2024 |
| SVB WEALTH LLC | - | - | - | -13,000 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -12,600 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -469 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -22 | -100.00% | - | Jun 30, 2024 |
X4 Pharmaceuticals's largest sold out institutional shareholder by shares sold is AVIDITY PARTNERS MANAGEMENT LP, sold -2.41M shares, valued at -, as of undefined.
X4 Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ROYCE MICRO-CAP TRUST, INC. | 0.80% | 388,363 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.21% | 107,908 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.05% | 12,196 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.05% | 10,021 | - | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 212,440 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 18,973 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 6,881,029 | -2,017,834 | -22.68% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 323,843 | - | - | Jan 31, 2024 |
| Simplify Exchange Traded Funds | 0.01% | 400,000 | - | - | Mar 28, 2024 |
| FORUM FUNDS II | 0.01% | 6,800 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,258,494 | -5,791 | -0.46% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 10,167 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 113,447 | -7,287 | -6.04% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 7,653 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 7,292 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 40,598 | -8,662 | -17.58% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,079 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 45,400 | 7,500 | 19.79% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 6,275 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 49,273 | -18,421 | -27.21% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,572 | 1,516 | 25.03% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 127,934 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 551,249 | 70,559 | 14.68% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,123 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 4,403,950 | -253,024 | -5.43% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 133 | - | - | Apr 30, 2021 |
| EQ ADVISORS TRUST | 0.00% | 275,482 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 17,455 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 4,800 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 47,249 | -191 | -0.40% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 19,812 | -4,191 | -17.46% | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 18,673 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 42,474 | 16,609 | 64.21% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 557 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 362,484 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 475 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 5,731 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 973 | -65 | -6.26% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 16,953 | 3,222 | 23.47% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 18,039 | 2,129 | 13.38% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 73 | - | - | Dec 31, 2023 |
| OLD WESTBURY FUNDS INC | 0.00% | 7,858 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 61,355 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 41,610 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 103,700 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 4,096 | - | - | Feb 29, 2024 |
| Investment Managers Series Trust | 0.00% | 53,963 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 13,949 | -56 | -0.40% | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,044 | - | - | Feb 29, 2024 |
| PGIM ETF TRUST | 0.00% | 1,588 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 51,592 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 6,786 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 78,146 | 2,579 | 3.41% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 44,764 | -2,414 | -5.12% | Mar 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 37,495 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 296 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 35,797 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 25,083 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 15,386 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 359 | 351 | 4387.50% | Jan 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 313 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 16,626 | 299 | 1.83% | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,988 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 532 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 129 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 4,100 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 2,540 | - | - | Feb 29, 2024 |
X4 Pharmaceuticals's largest mutual fund holder by % of total assets is "ROYCE MICRO-CAP TRUST, INC.", owning 388.36K shares, compromising 0.80% of its total assets.
X4 Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 27 | -73.79% |
| 31 Mar, 24 | 103 | 8.42% |
| 31 Dec, 23 | 95 | - |
| 30 Sep, 23 | 95 | -5.94% |
| 30 Jun, 23 | 101 | 68.33% |
| 31 Mar, 23 | 60 | 9.09% |
| 31 Dec, 22 | 55 | -5.17% |
| 30 Sep, 22 | 58 | 26.09% |
| 30 Jun, 22 | 46 | -20.69% |
| 31 Mar, 22 | 58 | 3.57% |
| 31 Dec, 21 | 56 | 5.66% |
| 30 Sep, 21 | 53 | -13.11% |
| 30 Jun, 21 | 61 | 1.67% |
| 31 Mar, 21 | 60 | 13.21% |
| 31 Dec, 20 | 53 | 3.92% |
| 30 Sep, 20 | 51 | -10.53% |
| 30 Jun, 20 | 57 | 11.76% |
| 31 Mar, 20 | 51 | -8.93% |
| 31 Dec, 19 | 56 | 12.00% |
| 30 Sep, 19 | 50 | 13.64% |
| 30 Jun, 19 | 44 | 51.72% |
| 31 Mar, 19 | 29 | - |
As of 30 Jun 24, 27 institutions are holding X4 Pharmaceuticals's shares, representing a decrease of -73.79% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 5,113,134 | -95.04% |
| 31 Mar, 24 | 103,000,336 | 6.45% |
| 31 Dec, 23 | 96,759,239 | -13.91% |
| 30 Sep, 23 | 112,393,217 | -2.78% |
| 30 Jun, 23 | 115,603,337 | 88.16% |
| 31 Mar, 23 | 61,438,161 | 5.54% |
| 31 Dec, 22 | 58,214,152 | 48.90% |
| 30 Sep, 22 | 39,096,365 | 143.55% |
| 30 Jun, 22 | 16,052,709 | -1.77% |
| 31 Mar, 22 | 16,341,441 | -6.99% |
| 31 Dec, 21 | 17,569,281 | 8.41% |
| 30 Sep, 21 | 16,206,515 | -2.30% |
| 30 Jun, 21 | 16,587,665 | 2.85% |
| 31 Mar, 21 | 16,127,509 | 53.92% |
| 31 Dec, 20 | 10,477,942 | 2.41% |
| 30 Sep, 20 | 10,231,751 | -7.26% |
| 30 Jun, 20 | 11,032,749 | -2.04% |
| 31 Mar, 20 | 11,262,347 | 1.92% |
| 31 Dec, 19 | 11,050,392 | 42.79% |
| 30 Sep, 19 | 7,738,957 | 1.90% |
| 30 Jun, 19 | 7,594,701 | 324.56% |
| 31 Mar, 19 | 1,788,831 | - |
X4 Pharmaceuticals (XFOR) has 5.11M shares outstanding as of 30 Jun 24, down -95.04% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 2.56% | 0.08% |
| 31 Mar, 24 | 57.93% | 2.40% |
| 31 Dec, 23 | 49.12% | 1.11% |
| 30 Sep, 23 | 66.61% | 1.06% |
| 30 Jun, 23 | 79.20% | 4.47% |
| 31 Mar, 23 | 42.09% | 1.26% |
| 31 Dec, 22 | 57.77% | 2.62% |
| 30 Sep, 22 | 46.98% | 12.62% |
| 30 Jun, 22 | 19.29% | 5.00% |
| 31 Mar, 22 | 19.64% | 4.41% |
| 31 Dec, 21 | 21.11% | 5.57% |
| 30 Sep, 21 | 19.48% | 4.90% |
| 30 Jun, 21 | 19.93% | 5.31% |
| 31 Mar, 21 | 19.38% | 12.22% |
| 31 Dec, 20 | 12.59% | 8.33% |
| 30 Sep, 20 | 12.30% | 6.99% |
| 30 Jun, 20 | 13.26% | 7.24% |
| 31 Mar, 20 | 13.53% | 7.67% |
| 31 Dec, 19 | 13.28% | 15.35% |
| 30 Sep, 19 | 9.30% | 11.16% |
| 30 Jun, 19 | 9.13% | 197.49% |
| 31 Mar, 19 | 2.15% | - |
As of 30 Jun 24, X4 Pharmaceuticals is held by 2.56% institutional shareholders, representing a 0.08% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 16 | -60.00% |
| 31 Mar, 24 | 40 | -11.11% |
| 31 Dec, 23 | 45 | 28.57% |
| 30 Sep, 23 | 35 | -52.70% |
| 30 Jun, 23 | 74 | 164.29% |
| 31 Mar, 23 | 28 | -3.45% |
| 31 Dec, 22 | 29 | -9.38% |
| 30 Sep, 22 | 32 | 100.00% |
| 30 Jun, 22 | 16 | -27.27% |
| 31 Mar, 22 | 22 | -12.00% |
| 31 Dec, 21 | 25 | 78.57% |
| 30 Sep, 21 | 14 | -46.15% |
| 30 Jun, 21 | 26 | -16.13% |
| 31 Mar, 21 | 31 | 14.81% |
| 31 Dec, 20 | 27 | 28.57% |
| 30 Sep, 20 | 21 | -36.36% |
| 30 Jun, 20 | 33 | 37.50% |
| 31 Mar, 20 | 24 | -40.00% |
| 31 Dec, 19 | 40 | 17.65% |
| 30 Sep, 19 | 34 | -12.82% |
| 30 Jun, 19 | 39 | 34.48% |
| 31 Mar, 19 | 29 | - |
16 institutional shareholders have increased their position in XFOR stock as of 30 Jun 24 compared to 40 in the previous quarter (a -60.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -92.00% |
| 31 Mar, 24 | 25 | 31.58% |
| 31 Dec, 23 | 19 | -29.63% |
| 30 Sep, 23 | 27 | 170.00% |
| 30 Jun, 23 | 10 | -9.09% |
| 31 Mar, 23 | 11 | 22.22% |
| 31 Dec, 22 | 9 | 125.00% |
| 30 Sep, 22 | 4 | -55.56% |
| 30 Jun, 22 | 9 | -43.75% |
| 31 Mar, 22 | 16 | 14.29% |
| 31 Dec, 21 | 14 | -33.33% |
| 30 Sep, 21 | 21 | 23.53% |
| 30 Jun, 21 | 17 | 13.33% |
| 31 Mar, 21 | 15 | 15.38% |
| 31 Dec, 20 | 13 | -31.58% |
| 30 Sep, 20 | 19 | 58.33% |
| 30 Jun, 20 | 12 | -25.00% |
| 31 Mar, 20 | 16 | 166.67% |
| 31 Dec, 19 | 6 | -14.29% |
| 30 Sep, 19 | 7 | 600.00% |
| 30 Jun, 19 | 1 | - |
| 31 Mar, 19 | - | - |
2 institutional shareholders have reduced their position in XFOR stock as of 30 Jun 24 compared to 25 in the previous quarter (a -92.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 27 | -73.79% | 5,113,134 | -95.04% | 2.56% | 0.08% | 16 | -60.00% | 2 | -92.00% |
| 31 Mar, 24 | 103 | 8.42% | 103,000,336 | 6.45% | 57.93% | 2.40% | 40 | -11.11% | 25 | 31.58% |
| 31 Dec, 23 | 95 | - | 96,759,239 | -13.91% | 49.12% | 1.11% | 45 | 28.57% | 19 | -29.63% |
| 30 Sep, 23 | 95 | -5.94% | 112,393,217 | -2.78% | 66.61% | 1.06% | 35 | -52.70% | 27 | 170.00% |
| 30 Jun, 23 | 101 | 68.33% | 115,603,337 | 88.16% | 79.20% | 4.47% | 74 | 164.29% | 10 | -9.09% |
| 31 Mar, 23 | 60 | 9.09% | 61,438,161 | 5.54% | 42.09% | 1.26% | 28 | -3.45% | 11 | 22.22% |
| 31 Dec, 22 | 55 | -5.17% | 58,214,152 | 48.90% | 57.77% | 2.62% | 29 | -9.38% | 9 | 125.00% |
| 30 Sep, 22 | 58 | 26.09% | 39,096,365 | 143.55% | 46.98% | 12.62% | 32 | 100.00% | 4 | -55.56% |
| 30 Jun, 22 | 46 | -20.69% | 16,052,709 | -1.77% | 19.29% | 5.00% | 16 | -27.27% | 9 | -43.75% |
| 31 Mar, 22 | 58 | 3.57% | 16,341,441 | -6.99% | 19.64% | 4.41% | 22 | -12.00% | 16 | 14.29% |
| 31 Dec, 21 | 56 | 5.66% | 17,569,281 | 8.41% | 21.11% | 5.57% | 25 | 78.57% | 14 | -33.33% |
| 30 Sep, 21 | 53 | -13.11% | 16,206,515 | -2.30% | 19.48% | 4.90% | 14 | -46.15% | 21 | 23.53% |
| 30 Jun, 21 | 61 | 1.67% | 16,587,665 | 2.85% | 19.93% | 5.31% | 26 | -16.13% | 17 | 13.33% |
| 31 Mar, 21 | 60 | 13.21% | 16,127,509 | 53.92% | 19.38% | 12.22% | 31 | 14.81% | 15 | 15.38% |
| 31 Dec, 20 | 53 | 3.92% | 10,477,942 | 2.41% | 12.59% | 8.33% | 27 | 28.57% | 13 | -31.58% |
| 30 Sep, 20 | 51 | -10.53% | 10,231,751 | -7.26% | 12.30% | 6.99% | 21 | -36.36% | 19 | 58.33% |
| 30 Jun, 20 | 57 | 11.76% | 11,032,749 | -2.04% | 13.26% | 7.24% | 33 | 37.50% | 12 | -25.00% |
| 31 Mar, 20 | 51 | -8.93% | 11,262,347 | 1.92% | 13.53% | 7.67% | 24 | -40.00% | 16 | 166.67% |
| 31 Dec, 19 | 56 | 12.00% | 11,050,392 | 42.79% | 13.28% | 15.35% | 40 | 17.65% | 6 | -14.29% |
| 30 Sep, 19 | 50 | 13.64% | 7,738,957 | 1.90% | 9.30% | 11.16% | 34 | -12.82% | 7 | 600.00% |
| 30 Jun, 19 | 44 | 51.72% | 7,594,701 | 324.56% | 9.13% | 197.49% | 39 | 34.48% | 1 | - |
| 31 Mar, 19 | 29 | - | 1,788,831 | - | 2.15% | - | 29 | - | - | - |
X4 Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of X4 Pharmaceuticals's stock was made by Taveras Arthur on Mar 11 2024, selling 14,235 shares at $0.88 per share (valued at $12.55K).
X4 Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 8 | - | - |
| Q1 2024 | 7 | 8 | 87.50% |
| Q4 2023 | 6 | 6 | 100.00% |
| Q3 2023 | 3 | 2 | 150.00% |
| Q2 2023 | 6 | 9 | 66.67% |
| Q1 2023 | - | 8 | - |
| Q4 2022 | 5 | - | - |
| Q3 2022 | - | 5 | - |
| Q2 2022 | 7 | 13 | 53.85% |
| Q1 2022 | 6 | 6 | 100.00% |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 1 | 11 | 9.09% |
| Q2 2021 | 14 | 9 | 155.56% |
| Q1 2021 | 5 | 3 | 166.67% |
| Q4 2020 | 5 | 4 | 125.00% |
| Q3 2020 | 8 | 7 | 114.29% |
| Q2 2020 | 7 | 10 | 70.00% |
| Q1 2020 | - | 1 | - |
| Q4 2019 | 1 | - | - |
| Q3 2019 | 1 | - | - |
8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by X4 Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 8 | - |
| Q4 2023 | - | 6 | - |
| Q3 2023 | 1 | 2 | 50.00% |
| Q2 2023 | - | 9 | - |
| Q1 2023 | - | 8 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 5 | - |
| Q2 2022 | - | 13 | - |
| Q1 2022 | - | 5 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 4 | - |
| Q2 2021 | - | 9 | - |
| Q1 2021 | - | 3 | - |
| Q4 2020 | - | 3 | - |
| Q3 2020 | - | 7 | - |
| Q2 2020 | - | 6 | - |
| Q1 2020 | - | 1 | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of X4 Pharmaceuticals's stocks.
X4 Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| MREO | Mereo BioPharma Group plc |
| DAWN | Day One Biopharmaceuticals, Inc. |
| PDSB | PDS Biotechnology Corporation |
| HOOK | HOOKIPA Pharma Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| ELEV | Elevation Oncology, Inc. |
XFOR Ownership FAQ
Who Owns X4 Pharmaceuticals?
X4 Pharmaceuticals is owned by institutional shareholders (2.56%), insiders (1.15%), and public (96.30%). The largest institutional shareholder of X4 Pharmaceuticals is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC (8.46% of total shares) and the top mutual fund owner is ROYCE MICRO-CAP TRUST, INC. (0.80% of total shares).
Who are the major institutional shareholders of X4 Pharmaceuticals?
X4 Pharmaceuticals's major institutional shareholders are BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, NEA MANAGEMENT COMPANY, LLC, BLACKROCK INC., VANGUARD GROUP INC, and ORBIMED ADVISORS LLC. The top five shareholders own together 29.00% of the company's share outstanding.
How many X4 Pharmaceuticals shareholders are there?
As of Jun 2024, there are 27 institutional shareholders of X4 Pharmaceuticals.
What percentage of X4 Pharmaceuticals is owned by BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC?
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC owns 16.92M shares of X4 Pharmaceuticals, representing 8.46% of the company's total shares outstanding, valued at $9.81M (as of Jun 2024).
What percentage of X4 Pharmaceuticals is owned by NEA MANAGEMENT COMPANY, LLC?
As of Jun 2024, NEA MANAGEMENT COMPANY, LLC holds 14.99M shares of X4 Pharmaceuticals (XFOR), compromising 7.49% of the company, valued at $8.69M.
What percentage of X4 Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of X4 Pharmaceuticals. The company owns 10.68M of the company's shares outstanding (worth $6.19M).